This article has been cited by
1Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I
Milena Sokolowska,G. Enrico Rovati,Zuzana Diamant,Eva Untersmayr,Jargen Schwarze,Zuzanna Lukasik,Florentina Sava,Alba Angelina,Oscar Palomares,Cezmi A. Akdis,Liam O’Mahony,Marek Sanak,Sven-Erik Dahlen,Grzegorz Woszczek
Allergy.2021;76(1)114
[DOI]
2Long-Term Omalizumab use in the Treatment of Exercise-Induced Anaphylaxis
Mark R. Peterson,Christopher A. Coop
Allergy & Rhinology.2017;8(3)ar.2017.8.0204
[DOI]
3Optimizing drug inhibition of IgE-mediated anaphylaxis in mice
Suzanne C. Morris,Charles Perkins,Crystal Potter,David Parsons,Richard Schuman,Marat V. Khodoun,Unni Samavedam,Richard Strait,Fred D. Finkelman
Journal of Allergy and Clinical Immunology.2021;8(3)ar.2017.8.0204
[DOI]
4Data on various allergen specific IgEs and prospective treatments on food-dependent exercise-induced anaphylaxis
Norihide Murayama,Kikuno Murayama
Data in Brief.2018;18(3)1895
[DOI]
  Feedback 
  Subscribe